Arkolith/Insider Trading/BNKL/Form 4

Gaston-Dreyfus Remi

Director, 10% OwnerBionik Laboratories Corp. (BNKL) · full profile →Form 4 · filed Dec 13, 2021
No Open-Market Flow
Open-Market Buys
$0
Open-Market Sells
$0
Net Open-Market Flow
$0
Transactions
4
2 non-derivative · 2 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jul 15, 2021Option exercise(M)116K——1.6M
Jul 15, 2021Option exercise(M)5K——1.6M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jul 15, 2021Option exercise(M)5K—$00
Jul 15, 2021Option exercise(M)116K—$00

Transaction Codes

M
Option exercise / conversion

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-21-149127) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML